Haemonetics Corp. buy Needham & Company LLC
Start price
18.03.25
/
50%
€58.50
Target price
18.03.26
€95.28
Performance (%)
-12.82%
Price
16.02.26
€48.80
Summary
This prediction is currently active. The price of Haemonetics Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.82%. This prediction currently runs until 18.03.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 0.826% | 0.826% |
| iShares Core DAX® | 0.388% | 0.145% |
| iShares Nasdaq 100 | 1.307% | -2.548% |
| iShares Nikkei 225® | -0.463% | 6.891% |
| iShares S&P 500 | 1.314% | -1.163% |
Comments by Needham___Company_LL for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $108.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€60.00
08.05.25
08.05.25
€74.16
08.05.26
08.05.26
-15.00%
16.02.26
16.02.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€104.18
07.02.26
07.02.26
-15.09%
08.02.26
08.02.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€80.50
03.12.24
03.12.24
€106.36
03.12.25
03.12.25
-14.29%
04.12.25
04.12.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€84.00
15.11.24
15.11.24
€106.41
15.11.25
15.11.25
-25.60%
16.11.25
16.11.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€79.00
12.06.24
12.06.24
€103.42
12.06.25
12.06.25
-24.68%
13.06.25
13.06.25